Bristlecone Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,304
| Closed | -$496K | – | 370 |
|
|
2024
Q2 | $496K | Sell |
6,304
-6,123
| -49% | -$502K | 0.04% | 185 |
|
|
2024
Q1 | $1.08M | Sell |
12,427
-8,599
| -41% | -$734K | 0.1% | 135 |
|
|
2023
Q4 | $1.73M | Sell |
21,026
-1,455
| -6% | -$111K | 0.18% | 108 |
|
|
2023
Q3 | $1.76M | Buy |
22,481
+981
| +5% | +$82.1K | 0.2% | 101 |
|
|
2023
Q2 | $1.89M | Sell |
21,500
-961
| -4% | -$82.7K | 0.19% | 102 |
|
|
2023
Q1 | $1.81M | Buy |
22,461
+324
| +1% | +$26.4K | 0.2% | 100 |
|
|
2022
Q4 | $1.72M | Sell |
22,137
-1,737
| -7% | -$141K | 0.21% | 97 |
|
|
2022
Q3 | $1.93M | Sell |
23,874
-176
| -0.7% | -$15.8K | 0.25% | 84 |
|
|
2022
Q2 | $2.16M | Buy |
24,050
+1,187
| +5% | +$120K | 0.27% | 77 |
|
|
2022
Q1 | $2.54M | Sell |
22,863
-928
| -4% | -$98K | 0.31% | 75 |
|
|
2021
Q4 | $2.46M | Sell |
23,791
-2,179
| -8% | -$252K | 0.3% | 80 |
|
|
2021
Q3 | $3.25M | Buy |
25,970
+55
| +0.2% | +$7.12K | 0.43% | 59 |
|
|
2021
Q2 | $3.22M | Sell |
25,915
-393
| -1% | -$49.3K | 0.44% | 57 |
|
|
2021
Q1 | $3.11M | Sell |
26,308
-4,834
| -16% | -$567K | 0.47% | 54 |
|
|
2020
Q4 | $3.65M | Buy |
31,142
+443
| +1% | +$48.8K | 0.58% | 42 |
|
|
2020
Q3 | $3.19M | Sell |
30,699
-561
| -2% | -$56.3K | 0.58% | 42 |
|
|
2020
Q2 | $2.87M | Sell |
31,260
-390
| -1% | -$37.4K | 0.58% | 43 |
|
|
2020
Q1 | $2.85M | Sell |
31,650
-1,857
| -6% | -$198K | 0.68% | 34 |
|
|
2019
Q4 | $3.8M | Buy |
33,507
+2,167
| +7% | +$238K | 0.76% | 31 |
|
|
2019
Q3 | $3.4M | Sell |
31,340
-967
| -3% | -$101K | 0.83% | 30 |
|
|
2019
Q2 | $3.15M | Buy |
32,307
+468
| +1% | +$42.7K | 0.75% | 35 |
|
|
2019
Q1 | $2.9M | Sell |
31,839
-526
| -2% | -$47.1K | 0.81% | 33 |
|
|
2018
Q4 | $2.94M | Buy |
32,365
+95
| +0.3% | +$8.88K | 0.88% | 27 |
|
|
2018
Q3 | $3.17M | Buy |
32,270
+12,426
| +63% | +$1.15M | 0.8% | 31 |
|
|
2018
Q2 | $1.7M | Sell |
19,844
-1,465
| -7% | -$122K | 0.57% | 43 |
|
|
2018
Q1 | $1.71M | Sell |
21,309
-4,636
| -18% | -$382K | 0.57% | 47 |
|
|
2017
Q4 | $2.1M | Buy |
25,945
+3,505
| +16% | +$281K | 0.66% | 43 |
|
|
2017
Q3 | $1.75M | Buy |
22,440
+400
| +2% | +$33.2K | 0.57% | 53 |
|
|
2017
Q2 | $1.96M | Buy |
22,040
+1,872
| +9% | +$158K | 0.66% | 47 |
|
|
2017
Q1 | $1.63M | Buy |
20,168
+411
| +2% | +$32.1K | 0.57% | 54 |
|
|
2016
Q4 | $1.41M | Buy |
19,757
+1,800
| +10% | +$141K | 0.5% | 65 |
|
|
2016
Q3 | $1.55M | Buy |
17,957
+372
| +2% | +$32.4K | 0.56% | 60 |
|
|
2016
Q2 | $1.53M | Buy |
17,585
+1,013
| +6% | +$81.9K | 0.56% | 61 |
|
|
2016
Q1 | $1.24M | Buy |
16,572
+750
| +5% | +$56.5K | 0.49% | 67 |
|
|
2015
Q4 | $1.22M | Buy |
+15,822
| New | +$1.19M | 0.51% | 62 |
|
Other funds holding MDT
Bristlecone Advisors's MDT Position: Q3 2024 in Review
Bristlecone Advisors sold out of Medtronic (MDT) in Q3 2024, closing a stake of 6,304 shares — an estimated $496K sold.
Bristlecone Advisors first reported a position in MDT in Q4 2015 and held it in 35 quarters. The position peaked at $3.8M in Q4 2019. 2,063 funds tracked by Wall St. Rank hold MDT as of Q3 2024.
- Bristlecone Advisors reported no remaining Medtronic position as of Q3 2024 after selling out during the quarter.
- Bristlecone Advisors sold 6,304 Medtronic shares in Q3 2024, an estimated $496K.
- Bristlecone Advisors first reported a position in Medtronic in Q4 2015 and held it in 35 quarters.
- Bristlecone Advisors's Medtronic position peaked at $3.8M in Q4 2019.
- 2,063 funds tracked by Wall St. Rank held Medtronic as of Q3 2024.
Based on Bristlecone Advisors's 13F filing for Q3 2024, filed 24 Oct 2024.